2026 Q1 -tulosraportti
33 päivää sitten
‧35 min
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 27.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 22.5. | ||
2025 Q4 -tulosraportti 19.2. | ||
2025 Q3 -tulosraportti 28.11.2025 | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2025 Q1 -tulosraportti 22.5.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·1 päivä sittenThe agenda for FEEDAP Panel Plenary #189 has arrived. Here is good news. Item 6.15 on the agenda is the discussion of phenylcapsaicin. The meeting runs from June 30 to July 2, and the minutes are typically available a couple of days later. If the data aXichem has presented here is good enough, then one should look for something along the lines of: "The Panel discussed the draft scientific opinion, and in particular assessed data regarding product safety. The Panel unanimously adopted the opinion." The full agenda can be found here: https://www.efsa.europa.eu/en/events/189th-plenary-meeting-feedap-panel It is also here that the minutes (Minutes) will be made available.
·19.2. · MuokattuNo impressive red figures 2025 and weak uncertain forecast going forward 2026. The price will likely end up a bit below 1 krona, perhaps already this afternoon!
·13.2. · MuokattuUgh, those issuance terms are really bad for the shareholders. That the new warrant which is exercised in September will be determined based on a future value and not already defined will cause the share price to fall a lot over the next 6 months unless there is wild news. Incredibly poor shareholder care
·4.2.The dilution is thus 12.5% in the first new share issue, for those who do not subscribe for any shares. The valuation is overvalued today! But uncertainty is probably what applies right now, hence this overreaction.- ·20.1.The perpetual application rolls on and it's time for the company to raise money without first being able to release good news. Unbelievable/ Outrageous....EFSA has requested the following: - Technical Dossier - List of annexes, references - Technical Dossier - Efficacy of the additive - Efficacy - Technical Dossier - Safety of the additive - Safety of use of the additive for consumers I find it reprehensible that it was not already included. Weren't these precisely the studies they had conducted? If that is the case, then fortunately it's not something new EFSA is requesting, and that was my initial fear. Torsten and the team need to get a move on and send the necessary material quickly so the process can move forward. What timeline can we expect before we move forward? Initially, a Clock Stop was called from 22-12-2022 to 21-03-2023. It was processed 26-28. September. Here we had output adopted 31-10-2023 and output published 12-12-2023. There are FEEDAP Panel meetings scheduled: 188: 5-6. May 189: 30. June-1. July 190: 9-10. September 191: 14-15. October.. 192: 24-25. November If everything runs as it should, we can probably expect processing no earlier than September. But that's a big if, because nothing in this process has really gone as it should. Sales in the EU will not happen in 2026. I would guess that we will need at least 12-18 months before we see it added to feed in the EU. And that is assuming they actually get the approval. There are no guarantees for that.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2026 Q1 -tulosraportti
33 päivää sitten
‧35 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·1 päivä sittenThe agenda for FEEDAP Panel Plenary #189 has arrived. Here is good news. Item 6.15 on the agenda is the discussion of phenylcapsaicin. The meeting runs from June 30 to July 2, and the minutes are typically available a couple of days later. If the data aXichem has presented here is good enough, then one should look for something along the lines of: "The Panel discussed the draft scientific opinion, and in particular assessed data regarding product safety. The Panel unanimously adopted the opinion." The full agenda can be found here: https://www.efsa.europa.eu/en/events/189th-plenary-meeting-feedap-panel It is also here that the minutes (Minutes) will be made available.
- ·19.2. · MuokattuNo impressive red figures 2025 and weak uncertain forecast going forward 2026. The price will likely end up a bit below 1 krona, perhaps already this afternoon!
- ·13.2. · MuokattuUgh, those issuance terms are really bad for the shareholders. That the new warrant which is exercised in September will be determined based on a future value and not already defined will cause the share price to fall a lot over the next 6 months unless there is wild news. Incredibly poor shareholder care
- ·4.2.The dilution is thus 12.5% in the first new share issue, for those who do not subscribe for any shares. The valuation is overvalued today! But uncertainty is probably what applies right now, hence this overreaction.
- ·20.1.The perpetual application rolls on and it's time for the company to raise money without first being able to release good news. Unbelievable/ Outrageous....EFSA has requested the following: - Technical Dossier - List of annexes, references - Technical Dossier - Efficacy of the additive - Efficacy - Technical Dossier - Safety of the additive - Safety of use of the additive for consumers I find it reprehensible that it was not already included. Weren't these precisely the studies they had conducted? If that is the case, then fortunately it's not something new EFSA is requesting, and that was my initial fear. Torsten and the team need to get a move on and send the necessary material quickly so the process can move forward. What timeline can we expect before we move forward? Initially, a Clock Stop was called from 22-12-2022 to 21-03-2023. It was processed 26-28. September. Here we had output adopted 31-10-2023 and output published 12-12-2023. There are FEEDAP Panel meetings scheduled: 188: 5-6. May 189: 30. June-1. July 190: 9-10. September 191: 14-15. October.. 192: 24-25. November If everything runs as it should, we can probably expect processing no earlier than September. But that's a big if, because nothing in this process has really gone as it should. Sales in the EU will not happen in 2026. I would guess that we will need at least 12-18 months before we see it added to feed in the EU. And that is assuming they actually get the approval. There are no guarantees for that.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 27.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 22.5. | ||
2025 Q4 -tulosraportti 19.2. | ||
2025 Q3 -tulosraportti 28.11.2025 | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2025 Q1 -tulosraportti 22.5.2025 |
2026 Q1 -tulosraportti
33 päivää sitten
‧35 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 27.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 22.5. | ||
2025 Q4 -tulosraportti 19.2. | ||
2025 Q3 -tulosraportti 28.11.2025 | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2025 Q1 -tulosraportti 22.5.2025 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·1 päivä sittenThe agenda for FEEDAP Panel Plenary #189 has arrived. Here is good news. Item 6.15 on the agenda is the discussion of phenylcapsaicin. The meeting runs from June 30 to July 2, and the minutes are typically available a couple of days later. If the data aXichem has presented here is good enough, then one should look for something along the lines of: "The Panel discussed the draft scientific opinion, and in particular assessed data regarding product safety. The Panel unanimously adopted the opinion." The full agenda can be found here: https://www.efsa.europa.eu/en/events/189th-plenary-meeting-feedap-panel It is also here that the minutes (Minutes) will be made available.
- ·19.2. · MuokattuNo impressive red figures 2025 and weak uncertain forecast going forward 2026. The price will likely end up a bit below 1 krona, perhaps already this afternoon!
- ·13.2. · MuokattuUgh, those issuance terms are really bad for the shareholders. That the new warrant which is exercised in September will be determined based on a future value and not already defined will cause the share price to fall a lot over the next 6 months unless there is wild news. Incredibly poor shareholder care
- ·4.2.The dilution is thus 12.5% in the first new share issue, for those who do not subscribe for any shares. The valuation is overvalued today! But uncertainty is probably what applies right now, hence this overreaction.
- ·20.1.The perpetual application rolls on and it's time for the company to raise money without first being able to release good news. Unbelievable/ Outrageous....EFSA has requested the following: - Technical Dossier - List of annexes, references - Technical Dossier - Efficacy of the additive - Efficacy - Technical Dossier - Safety of the additive - Safety of use of the additive for consumers I find it reprehensible that it was not already included. Weren't these precisely the studies they had conducted? If that is the case, then fortunately it's not something new EFSA is requesting, and that was my initial fear. Torsten and the team need to get a move on and send the necessary material quickly so the process can move forward. What timeline can we expect before we move forward? Initially, a Clock Stop was called from 22-12-2022 to 21-03-2023. It was processed 26-28. September. Here we had output adopted 31-10-2023 and output published 12-12-2023. There are FEEDAP Panel meetings scheduled: 188: 5-6. May 189: 30. June-1. July 190: 9-10. September 191: 14-15. October.. 192: 24-25. November If everything runs as it should, we can probably expect processing no earlier than September. But that's a big if, because nothing in this process has really gone as it should. Sales in the EU will not happen in 2026. I would guess that we will need at least 12-18 months before we see it added to feed in the EU. And that is assuming they actually get the approval. There are no guarantees for that.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt